Alabama Medical Marijuana Law

Status

Not Yet Operational

Law Signed:

2021

QUALIFYING CONDITIONS

Autism Spectrum Disorder (ASD)
Cancer-related cachexia, nausea or vomiting, weight loss, or chronic pain
Crohn’s Disease
Depression
Epilepsy or a condition causing seizures
HIV/AIDS-related nausea or weight loss
Panic disorder
Parkinson’s disease
Persistent nausea that is not significantly responsive to traditional treatment, except for nausea related to pregnancy, cannabis-induced cyclical vomiting syndrome, or cannabinoid hyperemesis syndrome
Post Traumatic Stress Disorder (PTSD)
Sickle Cell Anemia
Spasticity associated with a motor neuron disease, including Amyotrophic Lateral Sclerosis
Spasticity associated with Multiple Sclerosis or a spinal cord injury
Terminal illness
Tourette’s Syndrome
A condition causing chronic or intractable pain in which conventional therapeutic intervention and opiate therapy is contraindicated or has proved ineffective
* State law further requires recommending physicians to cite documentation indicating that “conventional medical treatment or therapy has failed” prior to issuing a medical cannabis recommendation.

PATIENT POSSESSION LIMITS

Registered patients are permitted to possess a maximum of “70 daily dosages” of medical cannabis at one time. Doses of authorized cannabis products are capped at a maximum of 50 milligrams for the first 90 days. Patients are not permitted access to cannabis flower material or cannabis-infused edible products. Rather, medical cannabis formulations must be in the form of: “tablets, capsules, tinctures, or gel cubes for oral use; gels, oils or creams for topical use, or suppositories, transdermal patches, nebulizers, or liquids or oils for use in an inhaler.” Patients age 18 or younger are limited to low-THC cannabis products.